主页 > 医学前沿 >
【drug-news】FDA批准Corifact用于阻止罕见XIII因子基
Corifact is 1st treatment for congenital Factor XIII Deficiency
The U.S. Food and Drug Administration today approved Corifact, the first product intended to prevent bleeding in people with the rare genetic defect congenital Factor XIII deficiency.
Patients with congenital Factor XIII deficiency don’t make enough Factor XIII, a substance that circulates in the blood and is important for normal clotting. Without treatment, people with the condition are at risk for life-threatening bleeding.
Congenital Factor XIII deficiency is rare and affects 1 out of every 3 million to 5 million people in the United States. The deficiency may lead to soft tissue bruising, mucosal bleeding and fatal intracranial bleeding. Newborns with Factor XIII deficiency may have umbilical cord bleeding.
“This product helps fill an important need,” said Karen Midthun, M.D., director of the FDA’s Center for Biologics Evaluation and Research.
Corifact received orphan-drug designation by the FDA because it is intended for use in a rare disease or condition. It was approved for marketing under the FDA's accelerated approval regulations that require an on-going study to demonstrate that patients actually receive the clinical benefit predicted by the data obtained so far.
The FDA approved Corifact based on results of a clinical study of 14 people, including children, with congenital Factor XIII deficiency. The most common side effects observed were hypersensitivity reactions (allergy, rash, pruritus, and erythema), chills, fever, arthralgia, headache, elevated thrombin-antithrombin levels, and an increase in liver (hepatic) enzymes.
Corifact is made from the pooled plasma of healthy donors. People receiving Corifact may develop antibodies against Factor XIII that may make the product ineffective. It potentially can cause adverse events from abnormal clotting if doses higher than the labeled dose are given to patients.
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm243856.htm 网站地图-2008-12-17To2008-12-18四川卧龙大熊猫今冬面临生存挑战 只有基因却没有血统 官方认证的法拉利摩托 梦是怎... 买一份不悔的心情(图) 经典文章 - 波西米亚风格 让最原始的生命力蓬勃展现(组图) 经典...www.feedou.com/...8-12-18.html-2009-11-16-快照-美国及英国的 食物安全管制及相关的环境卫生事宜文件类型:PDF/Adobe Acrobat- 文字版; 或指“任 何可供动物进食或植物摄取作为养料,以维持生命、提供营养及助长发育的物... in HHS News, 12 April 1998 (d.d. 16/03/99). 47 统计数据不单涉及食物业,还包括所有...www.legco.gov.hk/...9crp07.pdf-2010-12-22-H1N1的世纪大骗局drug additions and lethal side effects for millions. 据悉,医药延长寿命,但是堕落的生... persecution and arrest made the national news. 一个这样的威胁,可能的 H1N1 出血...www.wyzxsx.com/.../119344.html-2009-12-14-快照-[标签:content2]
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-02-18 13:52
医学,生命科学网